News
Cipla’s EU arm, Kemwell Biopharma to establish JV company in US
IMT News Desk
9 months ago
Cipla’s EU arm, Kemwell Biopharma to establish JV company in US
IMT News Desk
9 months ago
The JV business is being created to sell innovative cell treatment products in the EU, Japan, and the US
Cipla (EU), the fully owned subsidiary of Cipla, entered into a joint venture agreement with Kemwell Biopharma UK and MNI Ventures, Mauritius, for the establishment of a joint venture (JV) firm in the US.
The JV business is being created to sell innovative cell treatment products in the EU, Japan, and the US.
Cipla is a multinational pharmaceutical firm that meets every patient's daily needs by utilising innovation and state-of-the-art technology.